Laying Down the Chips

Looking to improve the quality of tools for discovering genomic regulatory regions, researchers at the National Institutes of Health combined Chromatin immunoprecipitation (ChIP) of hyper-acetylated histones, with serial analysis of gene expression (SAGE) technology. The process that they call genome-wide mapping technique (GMAT) could provide an alternative to ChIP-on-a-Chip techniques.1Developers and others call it unbiased and quantitatively better. "They sequence everything they bring down,

Written byCathy Holding
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Looking to improve the quality of tools for discovering genomic regulatory regions, researchers at the National Institutes of Health combined Chromatin immunoprecipitation (ChIP) of hyper-acetylated histones, with serial analysis of gene expression (SAGE) technology. The process that they call genome-wide mapping technique (GMAT) could provide an alternative to ChIP-on-a-Chip techniques.1

Developers and others call it unbiased and quantitatively better. "They sequence everything they bring down, and then BLAST it against the database," says Axel Imhof at Munich University. ChIP on a chip is limited to what's on the microarray, mostly open-reading frames not bound by regulatory molecules, he adds. Microarray sequences are often the whole gene in one spot, providing no information on where in the gene it is modified, adds Dirk Schubeler, at the Friedrich Miescher Institute for Biomedical Research in Switzerland. "What we want is a microarray of very small pieces. But then it's becoming so many spots ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies